ENSG Stock Analysis — The Ensign Group
Sector: Healthcare
AI Verdict
ENSG is cheap for the growth you're getting if its decentralized, margin-driven model keeps delivering, but any stumble could quickly erase the multiple premium.
Competitive Moat
Ensign Group operates skilled nursing and rehabilitation facilities, with a defensible moat built on operational expertise and local scale in fragmented post-acute care markets. Their decentralized management model allows for nimble adaptation to regulatory and reimbursement changes, making it hard for national chains to replicate their margins.
Summary
A 40.9% forward EPS growth forecast puts ENSG on the radar as one of the fastest-growing names in healthcare services.
Where It Stands
ENSG trades at 21.9x next year's earnings versus a healthcare sector median of 22x, with 18.9% trailing revenue growth and a 40.9% forward EPS growth consensus.
Key Metrics
- Trailing P/E: 30.8x
- Forward P/E: 21.9x
- PEG Ratio: 0.75
- Earnings Growth: +0.4%
- Revenue Growth: +0.2%
- Dividend Yield: 0.00%
- 52-Week High: $218.00
- 52-Week Low: $141.58
Analyst Consensus
10 Buy · 2 Hold · 0 Sell (12 analysts)
Bull Case
Paying 21.9x forward earnings for 40.9% expected EPS growth is cheap for the growth on offer if Ensign's local market advantage holds.
Bear Case
If the P/E multiple drops from 21.9x to the sector median of 18x, the stock could see a 17% valuation haircut even if earnings deliver.
Catalyst to Watch
Watch quarterly earnings for signs that facility-level margins and occupancy rates are sustaining the 40.9% EPS growth pace.